636
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Pulmonary Artery Abnormalities in Ex-smokers with and without Airflow Obstruction

, , , , , , & show all

References

  • Raherison C, Girodet P. Epidemiology of COPD. Euro Respir Rev 2009; 18(114):213–221.
  • Kirby M, Owrangi A, Svenningsen S, Wheatley A, Coxson HO, Paterson NA, et al. On the role of abnormal DLCO in ex-smokers without airflow limitation: symptoms, exercise capacity and hyperpolarised helium-3 MRI. Thorax 2013; 68(8):752–759.
  • Wells JM, Washko GR, Han MK, Abbas N, Nath H, Mamary AJ, et al. Pulmonary arterial enlargement and acute exacerbations of COPD. New Engl J Med 2012; 367(10):913–921.
  • Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Amer J Respir Crit Care Med 2007; 176(6):532–555.
  • Burge S, Wedzicha J. COPD exacerbations: definitions and classifications. Euro Respir J 2003; 21(41 suppl):46s–53s.
  • Gershon AS, Guan J, Victor JC, Goldstein R, To T. Quantifying health services use for chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 2013; 187(6):596–601.
  • Dransfield MT, Huang F, Nath H, Singh SP, Bailey WC, Washko GR. CT emphysema predicts thoracic aortic calcification in smokers with and without COPD. COPD: J Chroni Obstruct Pulmon Dis 2010; 7(6):404–410.
  • Chae EJ, Seo JB, Oh Y-M, Lee JS, Jung Y, Do Lee S. Severity of systemic calcified atherosclerosis is associated with airflow limitation and emphysema. J Comp Assist Tomogr 2013; 37(5):743–749.
  • McAllister DA, MacNee W, Duprez D, Hoffman EA, Vogel-Claussen J, Criqui MH, et al. Pulmonary function is associated with distal aortic calcium, not proximal aortic distensibility. MESA lung study. COPD 2011; 8(2):71–78.
  • Rasmussen T, Køber L, Pedersen JH, Dirksen A, Thomsen LH, Stender S, et al. Relationship between chronic obstructive pulmonary disease and subclinical coronary artery disease in long-term smokers. Euro Heart J–Cardiovasc Imag 2013; 14(12):1159–1166.
  • Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality–A randomized clinical trial. Ann Intern Med 2005; 142(4):233–239.
  • Sidney S, Sorel M, Quesenberry CP, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. CHEST J 2005; 128(4):2068–2075.
  • Iwamoto H, Yokoyama A, Kitahara Y, Ishikawa N, Haruta Y, Yamane K, et al. Airflow limitation in smokers is associated with subclinical atherosclerosis. Amer J Respir Crit Care Med 2009; 179(1):35–40.
  • Barr RG, Ahmed FS, Carr JJ, Hoffman EA, Jiang R, Kawut SM, et al. Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study. Euro Respir J 2012; 39(4):846–854.
  • Engström G, Hedblad B, Valind S, Janzon L. Asymptomatic leg and carotid atherosclerosis in smokers is related to degree of ventilatory capacity: longitudinal and cross-sectional results from ‘Men born in 1914’, Sweden. Atherosclerosis 2001; 155(1):237–243.
  • Lahousse L, van den Bouwhuijsen QJ, Loth DW, Joos GF, Hofman A, Witteman JC, et al. Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam Study. Amer J Respir Crit Care Med 2013; 187(1):58–64.
  • van Gestel YR, Flu W-J, van Kuijk J-P, Hoeks SE, Bax JJ, Sin DD, et al. Association of COPD with carotid wall intima-media thickness in vascular surgery patients. Respir Med 2010; 104(5):712–716.
  • Frantz S, Nihlén U, Dencker M, Engström G, Löfdahl CG, Wollmer P. Atherosclerotic plaques in the internal carotid artery and associations with lung function assessed by different methods. Clin Physiol Funct Imag 2012; 32(2):120–125.
  • Barr RG, Mesia-Vela S, Austin JH, Basner RC, Keller BM, Reeves AP, et al. Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: The Emphysema and Cancer Action Project (EMCAP) Study. Amer J Respir Crit Care Med 2007; 176(12):1200–1207.
  • Cinarka H, Kayhan S, Gumus A, Durakoglugil ME, Erdogan T, Ezberci I, et al. Arterial stiffness measured by carotid femoral pulse wave velocity is associated with disease severity in chronic obstructive pulmonary disease. Respir Care 2013; 59(2):274–280.
  • Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 2007; 175(12):1259–1265.
  • Kim S, Yoon D, Lee E, Hur G, Jung K, Lee S, et al. Carotid atherosclerosis in patients with untreated chronic obstructive pulmonary disease. Inter J Tubercul Lung Dis 2011; 15(9):1265–1270.
  • Pike D, Kirby M, Lindenmaier TJ, Sheikh K, Neron CE, Hackam DG, et al. Pulmonary abnormalities and carotid atherosclerosis in ex-smokers without airflow limitation. COPD 2014; 12(1):62–70.
  • Ackman Haimovici JB, Trotman-Dickenson B, Halpern EF, William Dec G, Ginns LC, Shepard J-AO, et al. Relationship between pulmonary artery diameter at computed tomography and pulmonary artery pressures at right-sided heart catheterization. Academ Radiol 1997; 4(5):327–334.
  • Kuriyama K, Gamsu G, Stern RG, Cann CE, Herfkens RJ, Brundage BH. CT-determined pulmonary artery diameters in predicting pulmonary hypertension. Investig Radiol 1984; 19(1):16–22.
  • Lange TJ, Dornia C, Stiefel J, Stroszczynski C, Arzt M, Pfeifer M, et al. Increased pulmonary artery diameter on chest computed tomography can predict borderline pulmonary hypertension. Pulmon Circul 2013; 3(2):363–368.
  • Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. New Engl J Med 2010; 363(12):1128–1138.
  • Global Initiative for Chronic Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (Updated 2013) 2013. Available from: http://www.goldcopd.org/ ( accessed September 6 2013).
  • Gudmundsson G, Ulrik CS, Gislason T, Lindberg E, Brøndum E, Bakke P, et al. Long-term survival in patients hospitalized for chronic obstructive pulmonary disease: a prospective observational study in the Nordic countries. Inter J Chron Obstruct Pulmon Dis 2012; 7:571–576.
  • Kirby M, Pike D, Coxson HO, McCormack DG, Parraga G. Hyperpolarized 3He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease. Radiology 2014; 273(3):887–896.
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26(2):319–338.
  • Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation: the St. George's Respiratory Questionnaire. Amer Rev Respir Dis 1992; 145(6):1321–1327.
  • Jones PW, Quirk F, Baveystock C. The St George's respiratory questionnaire. Respir Med 1991; 85:25–31.
  • Enright PL. The six-minute walk test. Respir Care 2003; 48(8):783–785.
  • Parraga G, Ouriadov A, Evans A, McKay S, Lam WW, Fenster A, et al. Hyperpolarized 3He ventilation defects and apparent diffusion coefficients in chronic obstructive pulmonary disease: preliminary results at 3.0 Tesla. Investig Radiol 2007; 42(6):384–391.
  • Kirby M, Svenningsen S, Owrangi A, Wheatley A, Farag A, Ouriadov A, et al. Hyperpolarized 3He and 129Xe MR imaging in healthy volunteers and patients with chronic obstructive pulmonary disease. Radiology 2012; 265(2):600–610.
  • Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, et al. Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Euro Respir J 2008; 31(4):869–873.
  • Shrimpton P, Jones D. Normalised organ doses for X-ray computed tomography calculated using Monte Carlo techniques and a mathematical anthropomorphic phantom. Radiat Protect Dosim 1993; 49(1–3):241–243.
  • Kirby M, Heydarian M, Svenningsen S, Wheatley A, McCormack DG, Etemad-Rezai R, et al. Hyperpolarized 3He magnetic resonance functional imaging semiautomated segmentation. Academ Radiol 2012; 19(2):141–152.
  • Woodhouse N, Wild JM, Paley MN, Fichele S, Said Z, Swift AJ, et al. Combined helium-3/proton magnetic resonance imaging measurement of ventilated lung volumes in smokers compared to never-smokers. J Magnet Reson Imag 2005; 21(4):365–369.
  • Kirby M, Heydarian M, Wheatley A, McCormack DG, Parraga G. Evaluating bronchodilator effects in chronic obstructive pulmonary disease using diffusion-weighted hyperpolarized helium-3 magnetic resonance imaging. J Appl Physiol 2012;112(4):651–657.
  • Nakano Y, Muro S, Sakai H, Hirai T, Chin K, Tsukino M, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers: correlation with lung function. Amer J Respir Crit Care Med 2000; 162(3):1102–1108.
  • Gevenois PA, De Maertelaer V, De Vuyst P, Zanen J, Yernault J-C. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Amer J Respir Crit Care Med 1995; 152(2):653–657.
  • Mishima M, Hirai T, Itoh H, Nakano Y, Sakai H, Muro S, et al. Complexity of terminal airspace geometry assessed by lung computed tomography in normal subjects and patients with chronic obstructive pulmonary disease. Proc Natl Acad Sci 1999; 96(16):8829–8834.
  • Ainsworth CD, Blake CC, Tamayo A, Beletsky V, Fenster A, Spence JD. 3D Ultrasound measurement of change in carotid plaque volume: A tool for rapid evaluation of new therapies. Stroke J Cereb Circul 2005; 36(9):1904–1909.
  • Lindenmaier TJ, Sheikh K, Bluemke E, Gyacskov I, Mura M, Licskai C, et al., editors. Three-dimensional segmentation of pulmonary artery volume from thoracic computed tomography imaging. In: Gimi, B, Molthen, RC (Eds.), Proceedings of Conference on Medical Imaging - Biomedical Applications in Molecular Structural and Functional Imaging, Orlando, FL. SPIE; February 24–26, 2015.
  • Lambert D. Zero-inflated Poisson regression, with an application to defects in manufacturing. Technometrics 1992; 34(1):1–14.
  • Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Euro Respir J 2008; 32(5):1371–1385.
  • Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Euro Respir J 2012; 40(6):1324–1343. doi: 10.1183/09031936.00080312. PubMed PMID: 22743675; PubMed Central PMCID: PMC3786581.
  • Mohamed Hoesein FA, Zanen P, Lammers JW. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011; 105(6):907–915. doi: 10.1016/j.rmed.2011.01.008. PubMed PMID: 21295958.
  • Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Amer J Respir Crit Care Med 1999; 159(1):158–164.
  • Franciosi LG, Page CP, Celli BR, Cazzola M, Walker MJ, Danhof M, et al. Markers of disease severity in chronic obstructive pulmonary disease. Pulmon Pharmacol Therap 2006; 19(3):189–199.
  • Gelb AF, Hogg JC, Müller NL, Schein MJ, Kuei J, Tashkin DP, et al. Contribution of emphysema and small airways in COPD. CHEST J 1996; 109(2):353–359.
  • Chan AL, Juarez MM, Shelton DK, MacDonald T, Li C-S, Lin T-C, et al. Novel computed tomographic chest metrics to detect pulmonary hypertension. BMC Med Imag 2011; 11(1):7.
  • Burger IA, Husmann L, Herzog BA, Buechel RR, Pazhenkottil AP, Ghadri JR, et al. Main pulmonary artery diameter from attenuation correction CT scans in cardiac SPECT accurately predicts pulmonary hypertension. J Nucl Cardiol 2011; 18(4):634–641.
  • Edwards P, Bull R, Coulden R. CT measurement of main pulmonary artery diameter. Br J Radiol 1998;71(850):1018–20.
  • Tan RT, Kuzo R, Goodman LR, Siegel R, Haasler GB, Presberg KW. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. CHEST J 1998;113(5):1250–1256.
  • Matsuoka S, Washko GR, Dransfield MT, Yamashiro T, San Jose Estepar R, Diaz A, et al. Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation. Acad Radiol 2010; 17(1):93–99. doi: 10.1016/j.acra.2009.07.022. PubMed PMID: 19796970; PubMed Central PMCID: PMC2790546.
  • Matsuoka S, Washko GR, Yamashiro T, Estepar RS, Diaz A, Silverman EK, et al. Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Amer J Respir Crit Care Med 2010; 181(3):218–225. doi: 10.1164/rccm.200908-1189OC. PubMed PMID: 19875683; PubMed Central PMCID: PMC2817812.
  • Matsuoka S, Yamashiro T, Matsushita S, Fujikawa A, Yagihashi K, Kurihara Y, et al. Relationship between quantitative CT of pulmonary small vessels and pulmonary perfusion. Amer J Roentgenol 2014; 202(4):719–724. doi: 10.2214/AJR.13.11027. PubMed PMID: 24660697.
  • Matsuoka S, Yamashiro T, Diaz A, Estepar RS, Ross JC, Silverman EK, et al. The relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease: quantitative CT analysis. Academ Radiol 2011; 18(1):40–46. doi: 10.1016/j.acra.2010.08.013. PubMed PMID: 20947389; PubMed Central PMCID: PMC3006041.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.